INTS·45828J103·US·equity·Healthcare - Biotechnology-13D/G
INTS (INTENSITY THERAPEUTICS INC) is held by 19 institutional investors as of Q4 2025. Largest holders: VANGUARD GROUP INC ($266,125), GEODE CAPITAL MANAGEMENT, LLC ($188,795), Creative Planning ($58,714). Net institutional sentiment: Bullish.
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer